[HTML][HTML] Metabolomics in degenerative brain diseases

MQ Escobar, JG de Moraes Pontes, L Tasic - Brain research, 2021 - Elsevier
Among the most studied diseases that affect the central nervous system are Parkinson's,
Alzheimer's, and Huntington's diseases, but the lack of effective biomarkers, accurate …

[HTML][HTML] The structural plasticity of polyglutamine repeats

PJB Pereira, JA Manso, S Macedo-Ribeiro - Current Opinion in Structural …, 2023 - Elsevier
From yeast to humans, polyglutamine (polyQ) repeat tracts are found frequently in the
proteome and are particularly prominent in the activation domains of transcription factors …

Drosophila as a Model of Unconventional Translation in Spinocerebellar Ataxia Type 3

SL Johnson, MV Prifti, A Sujkowski, K Libohova… - Cells, 2022 - mdpi.com
RNA toxicity contributes to diseases caused by anomalous nucleotide repeat expansions.
Recent work demonstrated RNA-based toxicity from repeat-associated, non-AUG-initiated …

Novel Metabolic Biomarkers and Therapeutic Strategies in Neurodegenerative Diseases

A Thapliyal, Shweta, SK Maurya - … : A Major Contributor of Comorbidities in …, 2024 - Springer
Metabolic changes are a major cause of pathophysiological alterations in
neurodegenerative diseases. Recent metabolic profiling studies have led to the …

[HTML][HTML] Mechanisms underlying polyglutamine diseases

J Lu - imperialbiosciencereview.wordpress …
Polyglutamine diseases are a group of nine inherited neurodegenerative diseases:
Huntington's disease (HD), Dentato-rubral pallidoluysian atrophy (DRPLA), spinal and …